The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trop-2 expression on treatment resistant cancer cells in castrate-resistant prostate cancer (CRPC) as a predictive biomarker for targeted therapy.
 
Kimberly Peihsi Ku
No Relationships to Disclose
 
Joshua Michael Lang
Stock and Other Ownership Interests - Salus Discovery
Consulting or Advisory Role - Sanofi; Sanofi
Research Funding - Agensys (Inst); Medivation (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - I am listed on the patent on a technology for rare cell capture and analysis. This technology has been licensed by Salus Discovery, LLC though no commercial products are available.
 
Jamie Sperger
No Relationships to Disclose
 
Scott Dehm
No Relationships to Disclose
 
Manish Kohli
No Relationships to Disclose
 
Liguo Wang
No Relationships to Disclose
 
Liewei Wang
No Relationships to Disclose
 
Scott T. Tagawa
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Endocyte; Genentech; Immunomedics; Janssen; Medivation; Sanofi
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech (Inst); Immunomedics (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst); Novartis (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Stem CentRx (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Howard I. Scher
Leadership - Asterias Biotherapeutics
Consulting or Advisory Role - Astellas Pharma; Blue Earth Diagnostics; Clovis Oncology; Elsevier; Ferring; Janssen Research & Development; Med IQ; Medivation; Merck; Roche; Sanofi; WIRB-Copernicus Group
Research Funding - Illumina (Inst); Innocrin Pharma (Inst); Janssen (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ferring; Medivation; Roche; WIRB-Copernicus Group